Research within the Division of Hematology/Oncology includes programs at the forefront of clinical, translational and basic science investigation. Clinical research activities are led by world-renowned faculty members developing innovative protocols and driving the standard of care in the treatment of cancer and other hematological diseases. Translational research is ongoing in many laboratories developing novel agents and strategies to address the clinically relevant issues with the goal of impacting patient care and disease management. A group of internationally recognized faculty leads the basic science research program within the division. These labs are involved in generating new knowledge that will expand our understanding of cellular processes critical in hematology and oncology.